E-LIB Suche - Ergebnisse für: Anargyrou, K.

1

PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CEL..:

Vassilakopoulos, T.P. ; Papageorgiou, S.G. ; Michail, M....
Hematological Oncology. 37 (2019) S2 - p. 266-267 , 2019

Link: https://doi.org/10.1002/..

2

Low bone mineral density and high bone turnover in patients..:

Anargyrou, K. ; Vassilakopoulos, T.P. ; Tsionos, K....
Bone. 48 (2011) - p. S254-S255 , 2011

Link: https://doi.org/10.1016/..

3

A014 High Serum TIMP-1 Correlates with Advanced Myeloma and..:

Terpos, E ; Dimopoulos, MA ; Shrivastava, V...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S5 , 2009

Link: https://doi.org/10.1016/..

4

An unusual case of CD4+ CD7+ CD56+ acute leukemia with over..:

Anargyrou, K. ; Paterakis, G. ; Boutsis, D....
European Journal of Haematology. 71 (2003) 4 - p. 294-298 , 2003

Link: https://doi.org/10.1034/..

5

Pulmonary Balantidium coli infection in a leukemic patient:

Anargyrou, K. ; Petrikkos, G.L. ; Suller, M.T.E....
American Journal of Hematology. 73 (2003) 3 - p. 180-183 , 2003

Link: https://doi.org/10.1002/..

6

Transient Monoclonal Hypergammaglobulinemia during the Cour..:

Valopoulos, G. ; Sideris, P. ; Anargyrou, K....
Infection. 30 (2002) 4 - p. 249-250 , 2002

Link: https://doi.org/10.1007/..

7

Prognostic factors in advanced stage Hodgkin's lymphoma: th..:

Vassilakopoulos, T.P. ; Angelopoulou, M.K. ; Siakantaris, M.P....
European Journal of Haematology. 67 (2001) 5-6 - p. 279-288 , 2001

Link: https://doi.org/10.1034/..

8

Retrospective evaluation of the risk profile in chronic mye..:

Terpos, E. ; Mantzourani, M. ; Stavroyianni, N....
European Journal of Cancer. 35 (1999) - p. S340 , 1999

Link: https://doi.org/10.1016/..

9

Positron emission tomography after response to rituximab-CH..:

Vassilakopoulos, Theodoros P. ; Papageorgiou, Sotirios G. ; Angelopoulou, Maria K....
Annals of Hematology. , 2021

Link: https://doi.org/10.1007/..

10

Low Bone Mineral Density and High Bone Turnover in Patients..:

Anargyrou, Konstantinos ; Fotiou, Despina ; Vassilakopoulos, Theodoros P....
HemaSphere. 3 (2019) 6 - p. e303 , 2019

Link: https://doi.org/10.1097/..

11

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma..:

Angelopoulou, Maria K. ; Vassilakopoulos, Theodoros P. ; Batsis, Ioannis...
Hematological Oncology. 36 (2017) 1 - p. 174-181 , 2017

Link: https://doi.org/10.1002/..

12

Bone metabolism markers and angiogenic cytokines as regulat..:

Tsirkinidis, Pantelis ; Terpos, Evangelos ; Boutsikas, Georgios...
Journal of Bone and Mineral Metabolism. 36 (2017) 4 - p. 399-409 , 2017

Link: https://doi.org/10.1007/..

13

Re‐evaluation of prognostic markers including staging, seru..:

Maltezas, Dimitrios ; Dimopoulos, Meletios A. ; Katodritou, Irene...
Hematological Oncology. 31 (2012) 2 - p. 96-102 , 2012

Link: https://doi.org/10.1002/..

14

Incorporating novel agents in the treatment of myelodysplas..:

Anargyrou, Konstantinos ; Vassilakopoulos, Theodoros P. ; Angelopoulou, Maria K..
Leukemia Research. 34 (2010) 1 - p. 6-17 , 2010

Link: https://doi.org/10.1016/..

15

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Res..:

Tsagarakis, Nikolaos J. ; Kentrou, Nektaria A. ; Papadimitriou, Konstantinos A....
Leukemia Research. 34 (2010) 4 - p. 438-446 , 2010

Link: https://doi.org/10.1016/..